Cargando…
Convalescent plasma for treatment of COVID-19: study protocol for an open randomised controlled trial in Sweden
INTRODUCTION: Although there are many studies on the use of convalescent plasma (CP) for treatment of COVID-19, it is not clear (1) which groups of patients may benefit, (2) what dose of plasma to give, or (3) which antibody levels the plasma should contain. Previous phase I/II studies and literatur...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655340/ https://www.ncbi.nlm.nih.gov/pubmed/34880010 http://dx.doi.org/10.1136/bmjopen-2020-048337 |